FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stimulator, Ultrasound And Muscle, For Use Other Than Applying Therapeutic Deep

PMA: P900009 · Supplement: S013 · Decision Sep 4, 2001
Classifications
1
FEI Numbers
2
Registration Numbers
2

Basic Information

Device Name
Stimulator, Ultrasound And Muscle, For Use Other Than Applying Therapeutic Deep
Trade Name
EXOGEN 2000+(TM) SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R))
PMA Number
P900009
Supplement Number
S013
Device Class
FDA Class 3
Product Code
LPQ
Generic Name
Stimulator, ultrasound and muscle, for use other than applying therapeutic deep
Medical Specialty
Unknown
Advisory Committee
Orthopedic
Decision
Approved
Decision Code
APPR
Decision Date
September 4, 2001
Date Received
April 30, 2001
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE LOW INTENSITY ULTRASOUND FRACTURE TREATMENT SYSTEM-SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R)). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME EXOGEN 2000+(TM) SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R)) AND IS INDICATED FOR THE NON-INVASIVE TREATMENT OF ESTBLISHED NONUNIONS* EXLUDING SKULL AND VERTEBRA. IN ADDITION, THE EXOGEN 2000+(TM) OR SONIC ACCELERATED FRACTURE HEALING SYSTEM (SAFHS(R)) IS INDICATED FOR ACCELERATING THE TIME TO A HEALED FRACTURE FOR FRESH, CLOSED, POSTERIORLY DISPLACED DISTAL RADIUS FRACTURES AND FRESH, CLOSED OR GRADE 1 OPEN TIBIAL DIAPHYSIS IN SKELETALLY MATURE INDIVIDUALS WHEN THESE FRACTURES ARE ORTHOPEDICALLY MANAGED BY CLOSED REDUCTION AND CAST IMMOBILIZATION. * A NONUNION IS CONSIDERED TO BE ESTABLISHED WHEN THE FRACTURE SITE SHOWS NO VISIBLY PROGRESSIVE SIGNS OF HEALING.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPQ Stimulator, Ultrasound And Muscle, For Use Other Than Applying Therapeutic Deep